A dedicated cardiovascular outcomes trial (SURPASS-CVOT) comparing tirzepatide to dulaglutide is ongoing, with results not yet published
This has the possibility of setting up a two-tier system whereby people who cant afford the more expensive drugs are only able to use drugs with less strong evidence of benefit, Krumholz said
Used to demolish a bag of chips watching hockey, now I forget the snacks are even there
Published studies underscore a common thread of weight regain after stopping GLP-1 medications, highlighting the need for nutritional products and lasting healthy, active lifestyle habits necessary for patients to retain their results over time
Semaglutide monotherapy, when dosed appropriately and escalated gradually, produces weight loss outcomes of 10-15% body weight reduction in clinical trialscomparable to or exceeding results historically attributed to phentermine combinations
Metformin is FDA-approved for type 2 diabetes and is sometimes prescribed off-label as part of weight management approaches